Pulmonary hypertension associated with connective tissue disease

被引：62

作者：

Fagan, KA ^{[1
]}

Badesch, DB ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Pulm Hypertens Ctr, Denver, CO 80202 USA

来源：

PROGRESS IN CARDIOVASCULAR DISEASES | 2002年 / 45卷 / 03期

关键词：

D O I：

10.1053/pcad.2002.129975

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pulmonary arterial hypertension is a life threatening complication of several connective tissue diseases including scleroderma (both diffuse and limited scleroderma, or the CREST syndrome - calcinosis cutis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangectasia), systemic lupus erythomatosis (SLE), mixed connective tissue disease (MCTD), and less commonly, rheumatoid arthritis (RA) and dermatomyositis/polymyositis. This report reviews the occurrence of this complication, potential etiologies, clinical presentation, and treatment options. Copyright 2002, Elsevier Science (USA). All rights reserved.

引用

页码：225 / 234

页数：10

共 50 条

[31] Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
Gaine, Sean
Chin, Kelly
Coghlan, Gerry
Channick, Richard
Di Scala, Lilla
Galie, Nazzareno
Ghofrani, Hossein-Ardeschir
Lang, Irene M.
McLaughlin, Vallerie
Preiss, Ralph
Rubin, Lewis J.
Simonneau, Gerald
Sitbon, Olivier
Tapson, Victor F.
Hoeper, Marius M.
EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
[32] Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Moccaldi, Beatrice
De Michieli, Laura
Binda, Marco
Famoso, Giulia
Depascale, Roberto
Perazzolo Marra, Martina
Doria, Andrea
Zanatta, Elisabetta
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
[33] Connective tissue disease-associated pulmonary arterial hypertension: "Beijing style"
Chung, Lorinda
Kawut, Steven M.
EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (04) : 839 - 841
[34] Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension
Kularatne, Mithum
Boucly, Athenais
Savale, Laurent
Solinas, Sabina
Cheron, Celine
Roche, Anne
Jevnikar, Mitja
Jais, Xavier
Montani, David
Humbert, Marc
Sitbon, Olivier
EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2101 - 2115
[35] Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease
Li, Xiaodi
Sun, Xiaoxuan
Huang, Yingheng
Wang, Yuanyuan
Yang, Xiaoman
Wang, Jingya
Zhang, Ning
Gu, Lei
Zhang, Miaojia
Wang, Qiang
CLINICAL RHEUMATOLOGY, 2019, 38 (12) : 3619 - 3626
[36] Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease
Xiaodi Li
Xiaoxuan Sun
Yingheng Huang
Yuanyuan Wang
Xiaoman Yang
Jingya Wang
Ning Zhang
Lei Gu
Miaojia Zhang
Qiang Wang
Clinical Rheumatology, 2019, 38 : 3619 - 3626
[37] Iloprost as Adjuvant to Sildenafil in Connective Tissue Disease-Associated Pulmonary Hypertension
Al Otair, Hadil A.
Al Hajjaj, Mohammed S.
Alhamad, Esam H.
Al Shamiri, Mostafa Q.
Ghaleb, Nabil B.
Al Arfaj, Abdulrahman S.
TURKISH THORACIC JOURNAL, 2013, 14 (03): : 88 - 92
[38] Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease
Oudiz, RJ
Schilz, RJ
Barst, RJ
Galié, N
Rich, S
Rubin, LJ
Simonneau, G
CHEST, 2004, 126 (02) : 420 - 427
[39] Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Rhee, Rennie L.
Gabler, Nicole B.
Praestgaard, Amy
Merkel, Peter A.
Kawut, Steven M.
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (09) : 2457 - 2465
[40] Pulmonary arterial hypertension associated to connective tissue diseases
Galiè, N
Manes, A
Farahani, KV
Pelino, F
Palazzini, M
Negro, L
Romanazzi, S
Branzi, A
LUPUS, 2005, 14 (09) : 713 - 717

← 1 2 3 4 5 →